XML 25 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues and other:      
Sales $ 755,290 $ 826,324 $ 851,834
Nonoperating Income (Expense) (67,294) 28,371 30,455
Total revenues, net of other expenses 687,996 854,695 882,289
Costs and expenses:      
Cost of Goods and Services Sold 558,967 641,140 679,665
Selling, general and administrative 84,246 76,598 67,929
Research and development 8,398 7,893 6,672
Amortization of identifiable intangibles 3,017 13,601 3,976
Accrued pension and postretirement benefits 14,720 9,642 10,406
Interest expense 2,587 4,051 5,702
Asset impairments and costs associated with exit and disposal activities, net of adjustments 1,725 784 398
Goodwill, Impairment Loss 13,696 0 0
Total 713,042 782,689 801,918
Income (loss) from continuing operations before income taxes (25,046) 72,006 80,371
Income tax expense (benefit) [1] (8,213) 13,545 18,807
Net income (loss) from continuing operations (16,833) 58,461 61,564
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax (58,611) (10,202) (36,722)
Net income (loss) $ (75,444) $ 48,259 $ 24,842
Basic:      
Continuing operations (in usd per share) $ (0.51) $ 1.76 $ 1.86
Discontinued operations (in usd per share) (1.75) (0.31) (1.11)
Net income (in usd per share) (2.26) 1.45 0.75
Diluted:      
Continuing operations (in usd per share) (0.51) 1.76 1.86
Discontinued operations (in usd per share) (1.75) (0.31) (1.11)
Net income (in usd per share) $ (2.26) $ 1.45 $ 0.75
Weighted Average Number of Shares Issued, Basic 33,402 33,236 33,068
Weighted Average Number of Shares Outstanding, Basic and Diluted 33,402 33,258 33,092
Shipping and Handling [Member]      
Costs and expenses:      
Cost of Goods and Services Sold $ 25,686 $ 28,980 $ 27,170
Other Cost of Operating Revenue $ 25,686    
[1] See Notes 1, 2, 3, 4 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.